Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Dongjin Semichem Co., Ltd. (005290.KQ)
Seoul, KR
Dongjin Semichem Co., Ltd. manufactures and supplies electronic materials and foaming agents. It offers azodicarbonamide, hydrazide, and UNICELL-G series for plastics and rubber; photoresist, a polymer compound that changes a specific pattern; stripper, a material that removes PR used in manufacturing LCDs and OLED panels; etchant, an acid that removes specific metals within a multilayer configuration to create microcircuit wiring; color resist, an organic composition that contains red, green, and blue pigments that emit light from the backlight; background electrode materials that coat the back of the electrode with a protective material for internal components, background electrode materials improve touch sensitivity by dissipating electricity into the conductive polymer layer; hard coating material; and touch screen. The company also provides semiconductor thinner that is used in edge bead removal process to remove unnecessary photoresist on the edge of silicon wafer after photoresist spin coating; CMP, a technology that mechanically flattens the wafer surface while chemically reacting by supplying slurry to the wafer surface; anti-reflective coating, a material that suppresses standing wave and notching; spin-on-carbon hardmask, which is used as the thickness of the photoresist film; precursor, a material that becomes a raw material for CVD/ALD; and melamine mold cleaner, an epoxy molding compound that is used to protect the package of semiconductor IC, and diode from impact. In addition, it offers fuel cell membrane electrode assembly, a component of fuel cells; and Li-ion battery conductive slurry that is applied to polymer batteries. The company was founded in 1967 and is headquartered in Seoul, South Korea.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.58% | -5.07% | +13.54% | +6.64% | +57.42% | +41.74% | +84.26% | +85.17% | +88.27% | +882.52% | +2,538.50% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-02 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +6.1%-15.2% Q1'26: -10.9% (vs Q1'25)
-
EPS growth Chemicals: +16.8%-36.0% Q1'26: +82.1% (vs Q1'25)
-
FCF margin Chemicals: +40.5%+2.7% Q1'26: +5.7% (vs Q1'25)
-
EBIT margin Chemicals: +8.2%+12.0% ★ Q1'26: +20.3% (vs Q1'25)
-
ROIC Chemicals: +4.4%+6.4% ★ Q1'26: +14.0% (vs Q1'25)
-
Share dilution Chemicals: +0.0%-5.0% ★ Q1'26: -2.0% (vs Q1'25)
-
Debt / EBITDA Chemicals: 0.31×3.16× Q1'26: 2.51× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
709.29B
est: 709.00B (+0.0%)
|
764.96B
est: 709.00B (+7.9%)
|
785.15B
est: 794.70B (-1.2%)
|
827.23B
est: 860.00B (-3.8%)
|
875.25B
est: 901.90B (-3.0%)
|
937.80B
est: 882.30B (+6.3%)
|
1.16T
est: 912.50B (+27.3%)
|
1.31T
est: 1.40T (-6.4%)
|
1.41T
est: 1.46T (-3.2%)
|
1.19T
est: 1.46T (-18.0%)
|
1.28T
1.28T – 1.28T
-12.4% YoY
|
1.38T
1.38T – 1.38T
+8.3% YoY
|
| EBITDA |
76.31B
est: 134.62B (-43.3%)
|
119.68B
est: 134.62B (-11.1%)
|
112.21B
est: 150.89B (-25.6%)
|
110.18B
est: 163.29B (-32.5%)
|
144.62B
est: 171.25B (-15.5%)
|
182.02B
est: 167.52B (+8.7%)
|
195.13B
est: 173.26B (+12.6%)
|
243.81B
est: 265.63B (-8.2%)
|
294.73B
est: 271.31B (+8.6%)
|
211.44B
est: 271.68B (-22.2%)
|
238.06B
238.06B – 238.06B
-12.4% YoY
|
257.88B
257.88B – 257.88B
+8.3% YoY
|
| EBIT |
40.90B
est: 104.30B (-60.8%)
|
46.14B
est: 104.30B (-55.8%)
|
70.94B
est: 116.91B (-39.3%)
|
74.78B
est: 126.52B (-40.9%)
|
102.86B
est: 132.68B (-22.5%)
|
136.01B
est: 129.80B (+4.8%)
|
146.33B
est: 134.24B (+9.0%)
|
187.83B
est: 205.81B (-8.7%)
|
230.41B
est: 206.81B (+11.4%)
|
143.50B
est: 207.10B (-30.7%)
|
181.47B
181.47B – 181.47B
-12.4% YoY
|
196.58B
196.58B – 196.58B
+8.3% YoY
|
| Net Income |
19.78B
est: 22.16B (-10.8%)
|
25.96B
est: 22.16B (+17.2%)
|
44.80B
est: 28.64B (+56.4%)
|
47.70B
est: 65.86B (-27.6%)
|
58.53B
est: 84.99B (-31.1%)
|
85.25B
est: 105.45B (-19.2%)
|
103.26B
|
127.31B
est: 146.94B (-13.4%)
|
154.78B
est: 146.83B (+5.4%)
|
99.07B
est: 153.96B (-35.7%)
|
148.98B
148.98B – 148.98B
-3.2% YoY
|
159.68B
159.68B – 159.68B
+7.2% YoY
|
| SGA |
26.10B
est: 42.40B (-38.5%)
|
30.87B
est: 42.40B (-27.2%)
|
32.63B
est: 47.53B (-31.3%)
|
37.50B
est: 51.43B (-27.1%)
|
35.28B
est: 53.94B (-34.6%)
|
67.22B
est: 52.77B (+27.4%)
|
78.12B
est: 54.57B (+43.1%)
|
84.57B
est: 83.67B (+1.1%)
|
50.69B
est: 81.90B (-38.1%)
|
64.60B
est: 82.01B (-21.2%)
|
71.86B
71.86B – 71.86B
-12.4% YoY
|
77.85B
77.85B – 77.85B
+8.3% YoY
|
| EPS |
443.01
est: 431.00 (+2.8%)
|
549.54
est: 431.00 (+27.5%)
|
899.72
est: 557.00 (+61.5%)
|
927.84
est: 1,281.00 (-27.6%)
|
1,138.33
est: 1,653.00 (-31.1%)
|
1,658.08
est: 2,051.00 (-19.2%)
|
2,008.47
|
2,476.00
est: 2,858.00 (-13.4%)
|
3,010.47
est: 3,007.00 (+0.1%)
|
1,926.89
est: 3,153.00 (-38.9%)
|
3,051.00
3,051.00 – 3,051.00
-3.2% YoY
|
3,270.00
3,270.00 – 3,270.00
+7.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-06 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-04 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-29 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-15 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-14 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-13 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-10 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Joon-Hyuk Lee | Chief Executive Officer, President & Chairman | — | male |
| Joon-Kyu Lee | President of Foaming Agent Business Division & Director | — | male |
| Yong-Hak Jung | MD & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 005290.KQ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
